Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of LY03005 vs Pristiq in Healthy Subjects
NCT02988024Phase 1Completed
- Sponsor
- Luye Pharma Group
- Start
- Dec 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of toludesvenlafaxine in major depressive disorder (MDD) (2 arms), sponsored by Luye Pharma Group. Primary endpoint: Area Under Curve at 4 days. Started Dec 2016; status: completed.
02
Drugs
toludesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02988024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02988024.